News | August 04, 2022
Merck KGaA posts higher earnings, profits across business segments
Despite the price increases for raw materials and logistics, EBITDA pre rose organically by 3.2% to € 1,782 million
Despite the price increases for raw materials and logistics, EBITDA pre rose organically by 3.2% to € 1,782 million
Better serving global partners and advancing healthcare innovation
Plant is part of the company's CAD $30 million capital investment in the site
AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing
Site Enhances New Modality CRDMO Platform Capacity for Customers
The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity
Brings 25 years of global operations and supply chain experience to Piramal
Both manufacturing facilities are based out of Benguluru, India
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
Subscribe To Our Newsletter & Stay Updated
